Navidea Biopharmaceuticals EPS - Earnings per Share 2010-2023 | NAVB
Navidea Biopharmaceuticals eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Navidea Biopharmaceuticals Annual EPS | |
|---|---|
| 2022 | $-0.56 |
| 2021 | $-0.40 |
| 2020 | $-0.48 |
| 2019 | $-0.76 |
| 2018 | $-1.89 |
| 2017 | $9.00 |
| 2016 | $-1.80 |
| 2015 | $-3.60 |
| 2014 | $-4.80 |
| 2013 | $-7.00 |
| 2012 | $-5.80 |
| 2011 | $1.20 |
| 2010 | $-14.40 |
| 2009 | $-10.80 |
| Navidea Biopharmaceuticals Quarterly EPS | |
|---|---|
| 2023-09-30 | $-0.02 |
| 2023-06-30 | $0.12 |
| 2023-03-31 | $-0.05 |
| 2022-12-31 | $-0.11 |
| 2022-09-30 | $-0.25 |
| 2022-06-30 | $-0.10 |
| 2022-03-31 | $-0.10 |
| 2021-12-31 | $-0.12 |
| 2021-09-30 | $-0.08 |
| 2021-06-30 | $-0.09 |
| 2021-03-31 | $-0.11 |
| 2020-12-31 | $-0.11 |
| 2020-09-30 | $-0.13 |
| 2020-06-30 | $-0.11 |
| 2020-03-31 | $-0.13 |
| 2019-12-31 | $-0.11 |
| 2019-09-30 | $-0.17 |
| 2019-06-30 | $-0.24 |
| 2019-03-31 | $-0.24 |
| 2018-12-31 | $-0.31 |
| 2018-09-30 | $-0.46 |
| 2018-06-30 | $-0.29 |
| 2018-03-31 | $-0.83 |
| 2017-12-31 | $-0.60 |
| 2017-09-30 | $-0.20 |
| 2017-06-30 | $-0.60 |
| 2017-03-31 | $10.40 |
| 2016-12-31 | $-0.59 |
| 2016-09-30 | $-0.01 |
| 2016-06-30 | $-0.80 |
| 2016-03-31 | $-0.40 |
| 2015-12-31 | $-0.40 |
| 2015-09-30 | $-1.00 |
| 2015-06-30 | $-1.20 |
| 2015-03-31 | $-1.00 |
| 2014-12-31 | $-0.80 |
| 2014-09-30 | $-1.00 |
| 2014-06-30 | $-1.40 |
| 2014-03-31 | $-1.60 |
| 2013-12-31 | $-2.20 |
| 2013-09-30 | $-1.80 |
| 2013-06-30 | $-1.80 |
| 2013-03-31 | $-1.20 |
| 2012-12-31 | $-1.40 |
| 2012-09-30 | $-1.80 |
| 2012-06-30 | $-1.20 |
| 2012-03-31 | $-1.40 |
| 2011-12-31 | $-1.60 |
| 2011-09-30 | $4.20 |
| 2011-06-30 | $-0.40 |
| 2011-03-31 | $-1.00 |
| 2010-12-31 | $-0.60 |
| 2010-09-30 | $-0.60 |
| 2010-06-30 | $-12.80 |
| 2010-03-31 | $-0.60 |
| 2009-12-31 | $0.00 |
| 2009-09-30 | $-6.80 |
| 2009-06-30 | $-4.20 |
| 2009-03-31 | $0.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $222.941B | 27.01 |
| Intuitive Surgical (ISRG) | United States | $143.600B | 86.51 |
| Edwards Lifesciences (EW) | United States | $53.017B | 34.50 |
| DexCom (DXCM) | United States | $50.653B | 76.73 |
| Alcon (ALC) | Switzerland | $44.098B | 31.60 |
| IDEXX Laboratories (IDXX) | United States | $42.656B | 50.00 |
| IQVIA Holdings (IQV) | United States | $41.833B | 24.27 |
| STERIS (STE) | Ireland | $22.645B | 26.46 |
| Waters (WAT) | United States | $19.959B | 29.33 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.158B | 0.00 |
| Hologic (HOLX) | United States | $17.223B | 19.27 |
| ShockWave Medical (SWAV) | United States | $12.545B | 78.07 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.470B | 14.56 |
| Sysmex ADR (SSMXY) | Japan | $10.712B | 33.59 |
| Teleflex (TFX) | United States | $9.720B | 15.13 |
| Globus Medical (GMED) | United States | $8.910B | 26.12 |
| Penumbra (PEN) | United States | $7.507B | 85.31 |
| Masimo (MASI) | United States | $6.742B | 38.84 |
| Glaukos (GKOS) | United States | $5.485B | 0.00 |
| TransMedics (TMDX) | United States | $4.621B | 438.41 |
| Integer Holdings (ITGR) | United States | $4.109B | 24.82 |
| PROCEPT BioRobotics (PRCT) | United States | $3.440B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.341B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.227B | 19.16 |
| Elekta AB (EKTAY) | Sweden | $3.078B | 21.12 |
| Inari Medical (NARI) | United States | $2.904B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.543B | 21.51 |
| RxSight (RXST) | United States | $2.262B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.231B | 9.73 |
| Veracyte (VCYT) | United States | $1.590B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.416B | 0.00 |
| Artivion (AORT) | United States | $0.992B | 95.12 |
| OPKO Health (OPK) | United States | $0.948B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.916B | 17.82 |
| Silk Road Medical (SILK) | United States | $0.865B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.775B | 0.00 |
| Paragon 28 (FNA) | United States | $0.649B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.628B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.602B | 20.45 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.559B | 0.00 |
| SiBone (SIBN) | United States | $0.558B | 0.00 |
| IRadimed (IRMD) | United States | $0.537B | 30.06 |
| Pacific Biosciences Of California (PACB) | United States | $0.509B | 0.00 |
| Nevro (NVRO) | United States | $0.345B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.320B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.306B | 10.45 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| AxoGen (AXGN) | United States | $0.274B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.247B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.227B | 0.00 |
| 908 Devices (MASS) | United States | $0.223B | 0.00 |
| NeuroPace (NPCE) | United States | $0.217B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.216B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.176B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.165B | 8.36 |
| ClearPoint Neuro (CLPT) | United States | $0.161B | 0.00 |
| CVRx (CVRX) | United States | $0.161B | 0.00 |
| Accuray (ARAY) | United States | $0.150B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.111B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.103B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.101B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.100B | 21.03 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Neuronetics (STIM) | United States | $0.065B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Envoy Medical (COCH) | United States | $0.054B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| LENSAR (LNSR) | United States | $0.048B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.035B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |